
Opinion|Videos|September 6, 2024
Billing With Intravenous and Subcutaneous Therapies
Author(s)Jennifer Seminerio, MD
Dr Seminerio highlights the differences in billing between intravenous and subcutaneous biologics.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is the difference in the billing process with IV and subQ therapies?
- What are the pros and cons of each?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5

























